DNA methylation analysis: Clinical Trials

4 trials of DNA methylation analysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Active not recruiting 1
Phase 21Completed 1

Follow DNA methylation analysis: new trials by email Literature Review of DNA methylation analysis trials Research Report on DNA methylation analysis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bevacizumab and Lomustine for Recurrent GBM
bevacizumab, lomustine, DNA methylation analysis - Glioblastoma Multiforme, Cognition Disorders
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC5922011-10-012021-02-15
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
temozolomide, DNA methylation analysis, laboratory biomarker analysis - Brain and Central Nervous System Tumors
Phase 3Active not recruitingEuropean Organisation for Research and Treatment of Cancer - EORTC7512007-12-012023-09-11
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
temozolomide, DNA methylation analysis, quality-of-life assessment - Brain and Central Nervous System Tumors
Phase 3CompletedCanadian Cancer Trials Group5622007-11-142023-08-22
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
alemtuzumab, arsenic trioxide, azacitidine - Leukemia, Myelodysplastic Syndromes
Phase 2 / Phase 3CompletedThe University of New South Wales20002006-08-012013-08-26

Conditions studied

Central Nervous System Neoplasms (2)  ·  Glioblastoma (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Cognition Disorders (1)  ·  Congenital Abnormalities (1)  ·  Gliosarcoma (1)  ·  Leukemia (1)  ·  Leukemia, Basophilic, Acute (1)  ·  Leukemia, Eosinophilic, Acute (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Canadian Cancer Trials Group (1)  ·  The University of New South Wales (1)

Countries

Netherlands (3)  ·  Canada (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Alan K. Burnett, MD, FRCP (1)  ·  Alba A. Brandes, MD (1)  ·  Anna Nowak, MD (1)  ·  James R. Perry, MD, FRCPC (1)  ·  Johan Menten, MD, PhD (1)  ·  Michael A. Vogelbaum, MD, PhD (1)  ·  Normand Laperriere, MD, FRCPC (1)  ·  S. Erridge (1)  ·  Warren P. Mason, MD (1)  ·  Wolfgang Wick (1)  ·  Wolfgang Wick, Pr. (1)

Results publications

PMID 24117272, PMID 27744512, PMID 28296618, PMID 28801186, PMID 29141164, PMID 32632894, PMID 34000245, PMID 35275197, PMID 41449147